Bank of Montreal’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-300
| Closed | -$6K | – | 3916 |
|
2024
Q2 | $6K | Hold |
300
| – | – | ﹤0.01% | 3397 |
|
2024
Q1 | $5.7K | Hold |
300
| – | – | ﹤0.01% | 3401 |
|
2023
Q4 | $5.99K | Hold |
300
| – | – | ﹤0.01% | 3394 |
|
2023
Q3 | $5.92K | Sell |
300
-335
| -53% | -$6.61K | ﹤0.01% | 3209 |
|
2023
Q2 | $13.5K | Hold |
635
| – | – | ﹤0.01% | 3368 |
|
2023
Q1 | $13.5K | Sell |
635
-478
| -43% | -$10.2K | ﹤0.01% | 3282 |
|
2022
Q4 | $25.9K | Hold |
1,113
| – | – | ﹤0.01% | 3198 |
|
2022
Q3 | $30 | Buy |
1,113
+670
| +151% | +$18 | ﹤0.01% | 3239 |
|
2022
Q2 | $10 | Sell |
443
-800
| -64% | -$18 | ﹤0.01% | 3386 |
|
2022
Q1 | $35K | Hold |
1,243
| – | – | ﹤0.01% | 3328 |
|
2021
Q4 | $50K | Hold |
1,243
| – | – | ﹤0.01% | 3163 |
|
2021
Q3 | $55K | Hold |
1,243
| – | – | ﹤0.01% | 3338 |
|
2021
Q2 | $50K | Buy |
1,243
+400
| +47% | +$16.1K | ﹤0.01% | 3287 |
|
2021
Q1 | $29K | Buy |
843
+143
| +20% | +$4.92K | ﹤0.01% | 3529 |
|
2020
Q4 | $24K | Hold |
700
| – | – | ﹤0.01% | 3859 |
|
2020
Q3 | $20K | Buy |
+700
| New | +$20K | ﹤0.01% | 3440 |
|